207 related articles for article (PubMed ID: 4551218)
21. C3 leukotactic factors produced by a tissue protease.
Hill JH; Ward PA
J Exp Med; 1969 Sep; 130(3):505-18. PubMed ID: 4185247
[TBL] [Abstract][Full Text] [Related]
22. Chemotactic factor inactivator in normal human serum.
Berenberg JL; Ward PA
J Clin Invest; 1973 May; 52(5):1200-6. PubMed ID: 4121701
[TBL] [Abstract][Full Text] [Related]
23. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
Schraufstatter IU; Discipio RG; Zhao M; Khaldoyanidi SK
J Immunol; 2009 Mar; 182(6):3827-36. PubMed ID: 19265162
[TBL] [Abstract][Full Text] [Related]
24. Analysis of density changes and chemotactic receptors of leukocytes from chronic hemodialysis and peritoneal dialysis patients.
Lewis SL; Van Epps DE; Chenoweth DE
Blood Purif; 1987; 5(2-3):138-54. PubMed ID: 3040039
[TBL] [Abstract][Full Text] [Related]
25. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
Rosenbaum JT; Wong K; Perez HD; Raymond W; Howes EL
Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1184-91. PubMed ID: 6384121
[TBL] [Abstract][Full Text] [Related]
26. Bacterial chaperone protein, Skp, induces leukocyte chemotaxis via C5a receptor.
Shrestha A; Shi L; Tanase S; Tsukamoto M; Nishino N; Tokita K; Yamamoto T
Am J Pathol; 2004 Mar; 164(3):763-72. PubMed ID: 14982830
[TBL] [Abstract][Full Text] [Related]
27. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
[TBL] [Abstract][Full Text] [Related]
28. Normal chemotactic migration of polymorphonuclear leukocytes stimulated with mononuclear-derived chemotactic factor in ulcerative colitis.
Hermanowicz A; Nawarska Z
Int Arch Allergy Appl Immunol; 1986; 81(1):63-8. PubMed ID: 3744579
[TBL] [Abstract][Full Text] [Related]
29. Complement and polymorphonuclear leukocytes do not determine the vascular permeability induced by intraocular LPS.
Howes EL; Wong KL; Hartiala KT; Webster RO; Rosenbaum JT
Am J Pathol; 1985 Jan; 118(1):35-42. PubMed ID: 3155595
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes.
van Epps DE; Chenoweth DE
J Immunol; 1984 Jun; 132(6):2862-7. PubMed ID: 6373920
[TBL] [Abstract][Full Text] [Related]
31. Inactivation of chemotactic activity of C5a by the serratial 56-kilodalton protease.
Oda T; Kojima Y; Akaike T; Ijiri S; Molla A; Maeda H
Infect Immun; 1990 May; 58(5):1269-72. PubMed ID: 1691142
[TBL] [Abstract][Full Text] [Related]
32. Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.
Kazmierowski JA; Gallin JI; Reynolds HY
J Clin Invest; 1977 Feb; 59(2):273-81. PubMed ID: 401834
[TBL] [Abstract][Full Text] [Related]
33. The effect of some protease substrates and inhibitors on chemotaxis and protease activity of human polymorphonuclear leukocytes.
Grady PG; Davis AT; Shapira E
J Infect Dis; 1979 Dec; 140(6):999-1003. PubMed ID: 396341
[TBL] [Abstract][Full Text] [Related]
34. Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5.
Orr W; Phan SH; Varani J; Ward PA; Kreutzer DL; Webster RO; Henson PM
Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1986-9. PubMed ID: 287038
[TBL] [Abstract][Full Text] [Related]
35. S19 ribosomal protein cross-linked dimer causes monocyte-predominant infiltration by means of molecular mimicry to complement C5a.
Nishiura H; Shibuya Y; Yamamoto T
Lab Invest; 1998 Dec; 78(12):1615-23. PubMed ID: 9881961
[TBL] [Abstract][Full Text] [Related]
36. Specific inhibitor of complement (C5)-derived chemotactic activity in systemic lupus erythematosus related antigenically to the Bb fragment of human factor B.
Perez HD; Hooper C; Volanakis J; Ueda A
J Immunol; 1987 Jul; 139(2):484-9. PubMed ID: 3648093
[TBL] [Abstract][Full Text] [Related]
37. Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes.
Snyderman R; Gewurz H; Mergenhagen SE
J Exp Med; 1968 Aug; 128(2):259-75. PubMed ID: 4873021
[TBL] [Abstract][Full Text] [Related]
38. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo.
DiScipio RG; Daffern PJ; Jagels MA; Broide DH; Sriramarao P
J Immunol; 1999 Jan; 162(2):1127-36. PubMed ID: 9916743
[TBL] [Abstract][Full Text] [Related]
39. Chemotaxis of polymorphonuclear leukocytes in response to surface-bound complement-derived chemoattractants generated in situ.
Dahlgren C; Hed J; Stendahl O
Inflammation; 1984 Jun; 8(2):201-8. PubMed ID: 6378792
[TBL] [Abstract][Full Text] [Related]
40. The roles of IgG, IgM rheumatoid factor, and their complexes in the induction of polymorphonuclear leukocyte chemotactic factor from complement.
Wagner T; Abraham G; Baum J
J Clin Invest; 1974 Jun; 53(6):1503-11. PubMed ID: 4133792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
